Changes in immune activation markers during pregnancy and postpartum

Journal of Reproductive Immunology

Volumn 42, Issue 2, 1999, Pages 147-165

  Burns, David N ^a   Nourjah, Parivash ^b   Wright, David J ^b   Minkoff, Howard ^c   Landesman, Sheldon ^c   Rubinstein, Arye ^d   Goedert, James J ^e   Nugent, Robert P ^a  

^a Adol Matern AIDS Br Ctr R   (United States)

^b WESTAT   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Biological markers; Hepatitis C; Immunity; Pregnancy; T lymphocytes

Indexed keywords

CD8 ANTIGEN; INTERLEUKIN 2 RECEPTOR; NEOPTERIN;

AGE; ARTICLE; DRUG ABUSE; FEMALE; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNOSTIMULATION; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PUERPERIUM; RACE DIFFERENCE; SCREENING TEST; VIRUS INFECTION;

ADULT; ANTIGENS, CD8; BIOLOGICAL MARKERS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; NEOPTERIN; POSTPARTUM PERIOD; PREGNANCY; RECEPTORS, INTERLEUKIN-2;

EID: 0033015467     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0378(98)00085-0     Document Type: Article

References (73)

1. Barcellini W., Rizzardi G.P., Velati C., Borghi M.O., Fain C., Lazzarin A., Meroni P.L. In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from high-risk HIV-negative intravenous drug users. AIDS. 9:1995;691-694.
2. Barnett M.A., Learmonth R.P., Pihl E., Wood E.C. T helper lymphocyte depression in early human pregnancy. J. Reprod. Immunol. 5:1983;55-57.
3. Bass H.Z., Nishanian P., Hardy W.D., Mitsuyasu R.T., Esmail E., Cumberland W., Fahey J.L. Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens. Clin. Immunol. Immunopathol. 64:1992;63-70.
4. Brettle R.P., Raab G.M., Ross A., Fielding K.L., Gore S.M., Bird A.G. HIV infection in women: immunological markers and the influence of pregnancy. AIDS. 9:1995;1177-1184.
5. Burns D.N., Landesman S., Muenz L.R., Nugent R.P., Goedert J.J., Minkoff H., Walsh J.H., Mendez H., Rubinstein A., Willoughby A. Cigarette smoking, premature rupture of membranes, and vertical transmission of HIV-1 among women with low CD4+ levels. J. Acquir. Immune Defic. Syndr. 7:1994;718-726.
6. Burns D.N., Nourjah P., Minkoff H., Korelitz J., Biggar R.J., Landesman S., Rubinstein A., Wright D., Nugent R.P. Changes in CD4+ and CD8+ cell levels during pregnancy and postpartum in women seropositive and seronegative for human immunodeficiency virus-1. Am. J. Obstet. Gynecol. 174:1996;1461-1468.
7. Castilla J.A., Rueda R., Vargas M.L., Gonzalez-Gomez F., Garcia-Olivares E. Decreased levels of circulating CD4+ T lymphocytes during normal human pregnancy. J. Reprod. Immunol. 15:1989;103-111.
8. Chaouat G., Menu E. Maternal T cell reactivity in pregnancy. Curr. Top. Microbiol. Immunol. 222:1997;103-126.
9. Diamondstone L.S., Tollerud D.J., Fuchs D., Wachter H., Brown L.M., Maloney E., Kurman C.C., Nelson D.L., Blattner W.A. Factors influencing serum neopterin and β2-microglobulin levels in a healthy diverse population. J. Clin. Immunol. 14:1994;368-374.
10. Di Franco M.J., Marlink R., Hunter D.J., Tosteson T., Mayer K., Essex M. Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects. J. Acquir. Immune Defic. Syndr. 6:1993;1297-1300.
11. Divers M.J., Miller D., Bulmer J.N., Vail A., Lilford R.J. Maternal levels of serum soluble CD8 and IL-2R are not significantly elevated in idiopathic preterm labor. Eur. J. Obstet. Gynecol. Reprod. Biol. 62:1995;209-212.
12. Djoulah S., Sanchez-Mazas A., Khalil I., Fenhamamouch S., Degos L., Deschamps I., Hors J. HLA-DRB1, DQA1 and DQB1 DNA polymorphisms in healthy Algerian and genetic relationships with other populations. Tissue Antigens. 43:1994;102-109.
13. Docke W.-D., Randow F., Syrbe U., Krausch D., Asadullah K., Reinke P., Volk H.-D., Kox W. Monocyte deactivation in septic patients: restoration by IFN-γ treatment. Nat. Med. 6:1997;678-681.
14. Donnelly R.P., Freeman S.L., Hayes M.P. Inhibition of IL-10 expression by IFN-γ up-regulates transcription of TNF-α in human monocytes. J. Immunol. 155:1995;1420-1427.
15. Fahey J.L., Taylor J.M.G., Detels R., Hofmann B., Melmed R., Nishanian P., Giorgi J.V. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type I. New Engl. J. Med. 322:1990;166-172.
16. Fuith L.C., Fuchs D., Hausen A., Hetzel H., Reibnegger G., Werner E.R., Wachter H. Neopterin, a marker of cell-mediated immune activation in human pregnancy. Int. J. Fertil. 36:1991;372-375.
17. Fujimoto J., Levy S., Levy R. Spontaneous release of the Leu-2 (T8) molecule from human T cells. J. Exp. Med. 158:1983;752-766.
18. Fujimoto J., Stewart S.J., Levy R. Immunochemical analysis of the released Leu-2 (T8) molecule. J. Exp. Med. 160:1984;116-124.
19. Gaston R.S. Factors affecting renal allograft survival in African Americans. Blood Purif. 14:1996;327-333.
20. Gessoni G., Valverde S., Giacomini A., Antico F., Manoni F. In subjects with antibody to hepatitis C virus a high serum level of interleukin-2 soluble receptor suggests activity of liver disease. J. Viral Hepatol. 5:1998;99-103.
21. Glassman A.B., Bennett C.E., Christopher J.B., Self S. Immunity during pregnancy: lymphocyte subpopulations and mitogen responsiveness. Ann. Clin. Lab. Sci. 15:1985;357-362.
22. Greenberg M., Jacobziner H., Pakter J., Weisl B.A.G. Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am. J. Obstet. Gynecol. 76:1958;897-902.
23. Griffin D.E., Ward B.J., Jauregui E., Johnson R.T., Vaisberg A. Immune activation in measles. New Engl. J. Med. 320:1989;1667-1672.
24. Hayashi J., Kishihara Y., Yamaji K., Yoshimura E., Ohmiya M., Tani Y., Ikematsu H., Kashiwagi S. Serum levels of soluble interleukin-2 receptors and the effects of interferon-alpha for patients with chronic hepatitis C virus. Dig. Dis. Sci. 40:1995;1837-1841.
25. Hofmann B., Bass H., Nishanian P., Faisal M., Figlin R.A., Sarna G.P., Fahey J.L. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha. Clin. Exp. Immunol. 88:1992;548-554.
26. Huber C., Batchelor J.R., Fuchs D., Hausen A., Lang A., Niederwieser D., Reibnegger G., Swetly P., Troppmair J., Wachter H. Immune response-associated production of neopterin: release from macrophages primarily under control of interferon-gamma. J. Exp. Med. 160:1984;310-316.
27. Hunt J.S., Vassmer D., Ferguson T.A., Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol. 158:1997;4122-4128.
28. Jiang J.D., Schlesinger M., Sacks H., Mildvan D., Roboz J.P., Bekesi J.G. Concentrations of soluble CD95 and CD8 antigens in the plasma and levels of CD8+CD95+, CD8+CD38+, and CD4+CD95+ T cells are markers for HIV-1 infection and clinical status. J. Clin. Immunol. 17:1997;185-192.
29. Johnstone F.D., Thong K.J., Bird A.G., Whitelaw J. Lymphocyte subpopulations in early human pregnancy. Obstet. Gynecol. 83:1994;941-946.
30. Kimura M., Hanawa H., Watanabe H., Mitsuru O., Abo T. Synchronous expansion of intermediate TCR cells in the liver and uterus during pregnancy. Cell Immunol. 162:1995;16-25.
31. α secretion from human peripheral blood mononuclear cells: A dose-response study in vitro. Immunol. Lett. 59:1997;29-33.
32. Krasnow J.S., Tollerud D.J., Naus G., DeLoia J.A. Endometrial Th2 cytokine expression throughout the menstrual cycle and early pregnancy. Hum. Reprod. 11:1996;1747-1754.
33. Laird N.M., Ware J.H. Random effects models for longitudinal data. Biometrics. 38:1982;963-974.
34. Lencki S.G., Maciulla M.B., Eglinton G.S. Maternal and umbilical cord serum interleukin levels in preterm labor with clinical chorioamnionitis. Am. J. Obstet. Gynecol. 170:1994;1345-1351.
35. Leonardi S., Avola E., Sciacca A., Di Gregorio F., Musumeci S. Neopterin as a marker of C hepatitis in thalessaemia major. J. Pediatr. Gastroenterol. Nutr. 12:1991;315-318.
36. Lucey D.R., Hendrix C.W., Andrzejewki C., Melcher G.P., Butzin C.A., Henry R., Wians F.H. Jr., Boswell R.N. Comparison by race of total serum IgG, IgA, and IgM with CD4+ T-cell counts in North American persons infected with the human immunodeficiency virus type 1. J. Acquir. Immune. Defic. Syndr. 5:1992;325-332.
37. MacLean M.A., Wilson R., Thomson J.A., Krishnamurthy S., Walker J.J. Changes in immunologic parameters in normal pregnancy and spontaneous abortion. Am. J. Obstet. Gynecol. 165:1991;890-895.
38. MacLean M.A., Wilson R., Thomson J.A., Krishnamurthy S., Walker J.J. Immunological changes in normal pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 43:1992;167-172.
39. Mantzavinos T., Phocas I., Sarandakou A., Kanakas N., Arvaniti K., Zourlas P.A. Serum markers of immune activation in women undergoing in-vitro fertilization and embryo transfer. Hum. Reprod. 11:1996;2412-2417.
40. Marzusch K., Buchholz F., Ruck P., Handgretinger R., Geiselhart A., Engelmann L., Dietl J. Interleukin-12- and interleukin-2-stimulated release of interferon-γ by uterine CD56++ large granular lymphocytes is amplified by decidual macrophages. Hum. Reprod. 12:1997;921-924.
41. Mast E.E., Purdy M.A., Krawczynski K. Hepatitis E. Baillière Clin. Gastroenterol. 10:1996;227-242.
42. Matthiesen L., Berg F., Ernerudh J., Hakansson L. Lymphocyte subsets and mitogen stimulation of blood lymphocytes in normal pregnancy. Am. J. Reprod. Immunol. 35:1996;70-79.
43. Mikyas Y., Aziz N., Harawa N., Gorre M., Neagos-Nogueira M., Wafer D., Dillon M., Boyer P.J., Bryson Y.J., Plaeger S. Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. J. Reprod. Immunol. 33:1997;157-170.
44. Miotti P.G., Liomba G., Dallabetta G.A., Hoover D.R., Chiphangwi J.D., Saah A.J. T lymphocyte subsets during and after pregnancy: analysis in human immunodeficiency virus type 1-infected and -uninfected Malawian mothers. J. Infect. Dis. 165:1992;1116-1119.
45. Nagata S. Fas and Fas ligand: a death factor and its receptor. Adv. Immunol. 57:1994;129-144.
46. Nahmias A.J., Kourtis A.P. The great balancing acts: The pregnant woman, placenta, fetus, and infectious agents. Clin. Perinatol. 24:1997;497-521.
47. Pickard R.E. Varicella pneumonia in pregnancy. Am. J. Obstet. Gynecol. 101:1968;504-508.
48. Pope R.M. Immunoregulatory mechanisms present in the maternal circulation during pregnancy. Baillière Clin. Rheum. 4:1990;33-52.
49. Prince H.E., Kleinman S., Czaplicki C., John J., Williams A.E. Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection. J. Acquir. Immune Defic. Syndr. 3:1990;525-530.
50. Quiroga J.A., Martin J., Pardo M., Carreno V. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha. Dig. Dis. Sci. 39:1994;2485-2496.
51. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol. Today. 18:1997;478-482.
52. Rich K.C., Siegel J.N., Jennings C., Rydman R.J., Landay A.L. CD4+ lymphocytes in perinatal human immunodeficiency virus (HIV) infection: evidence for pregnancy induced depression in uninfected and HIV infected women. J. Infect. Dis. 172:1995;1221-1227.
53. Ridge, J.P., Dirosa, F., Matzinger, P., 1998. A conditioned dendriric cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 393, 474-478.
54. Riley, J.P., Olerup, O., 1992. HLA polymorphisms and evolution. Immunol. Today 13, 333-335.
55. Rubin, L.A., Kurman, C.C., Fritz, M.E., Biddison, W.E., Boutin, B., Yarchoan, R., Nelson, D.L., 1985. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J. Immunol. Res. 135, 3172-3177.
56. Rubin L.A., Nelson D.L. The soluble interleukin-2 receptor: biology, function, and clinical application. Ann. Intern. Med. 113:1990;619-627.
57. Sabahi F., Rola-Plesczcynski M., O'Connell S., Frenkel L.D. Qualitative and quantitative analysis of T lymphocytes during normal human pregnancy. Am. J. Reprod. Immunol. 33:1995;381-392.
58. Schwartz L.B. Understanding human parturition. Lancet. 350:1997;1792-1793.
59. Shahabuddin S. Quantitative differences in CD8+ lymphocytes, CD4/CD8 ratio, NK cells, and HLA-DR(+)-activated T cells of racially different male populations. Clin. Immunol. Immunopathol. 75:1995;168-170.
60. Sridma V., Furio P., Yang S.-L., Moawad A., Reilly M., DeGroot L.J. Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy. New Engl. J. Med. 307:1982;352-356.
61. Strickler H.D., Blanchard J.F., Vlahov D., Taylor E., Munoz A., Nelson K.E., Margolick J.B. Elevated levels of neopterin but not β2-microglobulin in HIV-1-seronegative injecting drug users. AIDS. 7:1993;361-367.
62. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178.
63. Suzuki T., Hiromatsu K., Ando Y., Okamoto T., Tomoda Y., Yoshikai Y. Regulatory role of γδ T cells in uterine intraepithelial lymphocytes in maternal antifetal immune response. J. Immunol. 154:1995;4476-4484.
64. Tollerud D.J., Kurman C.C., Nelson D.L., Brown L.M., Maloney E.M., Blattner W.A. Racial variation in serum-soluble interleukin-2 receptor levels: a population-based study of healthy smokers and nonsmokers. Clin. Immunol. Immunopathol. 70:1994;274-279.
65. Tomkinson B.E., Brown M.C., Ip S.H., Carrabis S., Sullivan J.L. Soluble CD8 during T cell activation. J. Immunol. 142:1989;2230-2236.
66. α from and activation of native human peripheral blood mononuclear cells by recombinant IL-15. Clin. Immunol. Immunopathol. 80:1996;67-75.
67. Vanderbeeken Y., Vleighe M.P., Delespesse G., Duchateau J. Characterization of immunoregulatory T cells during pregnancy by monoclonal antibodies. Clin. Exp. Immunol. 48:1982;118-120.
68. Wachter H., Fuchs D., Hausen A., Reibnegger G., Werner E.R. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv. Clin. Chem. 27:1989;81-141.
69. Wang H., Zhang M., Soda K., Sama A., Tracey K.J. Fetuin protects the fetus from TNF. Lancet. 350:1997;861-862.
70. Watanabe M., Iwatani Y., Hidaka Y., Mitsuda N., Amino N. Changes in soluble CD4 and CD8 proteins in healthy pregnant and postpartum women. Am. J. Reprod. Immunol. 36:1996;220-227.
71. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a Th2 phenomenon? Immunol. Today. 14:1993;353-356.
72. Weinberg E.D. Pregnancy-associated depression of cell-mediated immunity. Rev. Infect. Dis. 6:1984;814-831.
73. Yagi M.J., Chu F.-N., Jiang J.D., Wallace J., Mason P., Liu Y., Carafa J., Bekesi J.G. Increases in soluble CD8 antigen in plasma and CD8+ and CD8+CD38+ cells in human immunodeficiency virus type-1 infection. Clin. Immunol. Immunopathol. 63:1992;126-134.